Edwards Lifesciences (EW) PT Lowered to $108 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $94.44 +2.90%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 27 | New: 16
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 27 | New: 16
Join SI Premium – FREE
Morgan Stanley analyst Cecilia Furlong lowered the price target on Edwards Lifesciences (NYSE: EW) to $108.00 (from $119.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Exlservice (EXLS) PT Raised to $48 at Stifel
- Kymera Therapeutics (KYMR) PT Raised to $140 at Oppenheimer
- CNX Resources (CNX) PT Raised to $39 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
